RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM) Conference

Gilbert, MR, Wang, M, Aldape, K et al. (2009). RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM) . JOURNAL OF CLINICAL ONCOLOGY, 27(15),

cited authors

  • Gilbert, MR; Wang, M; Aldape, K; Lassman, A; Sorensen, AG; Mikkelson, T; Groves, M; Werner-Wasik, M; Regine, W; Mehta, M

sustainable development goals

authors

date/time interval

  • May 29, 2009 -

publication date

  • May 20, 2009

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Orlando, FL

Conference

  • 45th Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 27

issue

  • 15